Fingerprint
Dive into the research topics where Luhua Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma
Wang, Y., Larson, M. C., Hwang, S. R., Villa, D., Kugathasan, L., Kumar, A., Joseph, A., Brooks, T. R., Hill, B. T., Bond, D. A., Maddocks, K. J., Nizamuddin, I. A., Kahl, B. S., Danilov, A., Argao, C., Ruan, J., Ryan, C. E., Merryman, R. W., Grover, N. S. & Khan, N. B. & 36 others, , Feb 24 2026, In: Blood Advances. 10, 4, p. 1372-1380 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 cohort 3
van Meerten, T., Kersten, M. J., Iacoboni, G., Hess, G., Mutsaers, P., García-Sancho, A. M., Goy, A., Giné, E., Hill, B. T., Weng, W. K., Reagan, P. M., Patel, K., Galal, A., Herbaux, C., Sanderson, R., Forcade, E., Topp, M. S., Houot, R., Zheng, D. & Zhang, W. & 6 others, , Mar 19 2026, In: Blood. 147, 12, p. 1302-1314 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma (Experimental Hematology & Oncology, (2024), 13, 1, (14), 10.1186/s40164-024-00484-9)
Yan, F., Jiang, V., Jordan, A., Che, Y., Liu, Y., Cai, Q., Xue, Y., Li, Y., McIntosh, J., Chen, Z., Vargas, J., Nie, L., Yao, Y., Lee, H. H., Wang, W., Bigcal, J. N. R., Badillo, M., Meena, J., Flowers, C. & Zhou, J. & 3 others, , Dec 2026, In: Experimental Hematology and Oncology. 15, 1, 19.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Correction: Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations (Blood Cancer Journal, (2023), 13, 1, (27), 10.1038/s41408-023-00799-6)
Che, Y., Liu, Y., Yao, Y., Hill, H. A., Li, Y., Cai, Q., Yan, F., Jain, P., Wang, W., Rui, L. & Wang, M., Dec 2026, In: Blood cancer journal. 16, 1, 56.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Dissecting Pirtobrutinib Resistance in Mantle Cell Lymphoma Through Single-Cell Multi-Omics
Yan, F., Liu, Y., Lee, H.-H., Wang, W., McIntosh, J., Li, Y., Vargas, J., Fei, Y., Ahmed, S., Simon, L. M. & Wang, L., 2026, (Accepted/In press) In: American journal of hematology.Research output: Contribution to journal › Article › peer-review
Open Access